FMC
31
-3
APA
30
5
DG
36
-2
JBHT
28
-14
MS
70
-2
BRK.B
47
2
UA
35
-13
PVH
67
-2
ABBV
64
4
VRSK
84
2
EOG
49
4
MPC
44
5
RCL
62
-3
STX
59
-5
PSA
48
2
ECL
84
2
HAL
50
4
REGN
65
2
MNST
59
2
WM
80
-4
FMC
31
-3
APA
30
5
DG
36
-2
JBHT
28
-14
MS
70
-2
BRK.B
47
2
UA
35
-13
PVH
67
-2
ABBV
64
4
VRSK
84
2
EOG
49
4
MPC
44
5
RCL
62
-3
STX
59
-5
PSA
48
2
ECL
84
2
HAL
50
4
REGN
65
2
MNST
59
2
WM
80
-4
Financhill
Back

Relay Therapeutics Stock Predictions

Sell
36

RLAY
Relay Therapeutics

Last Price:
6.64
Seasonality Move:
11.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Relay Therapeutics Stock Forecast

  • Over the next 52 weeks, Relay Therapeutics has on average historically fallen by 39.6% based on the past 3 years of stock performance.
  • Relay Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Relay Therapeutics Stock Undervalued?
    The current Relay Therapeutics [RLAY] share price is $6.64. The Score for RLAY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • RLAY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Relay Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Relay Therapeutics has on average historically fallen by 39.6% based on the past 3 years of stock performance.

Relay Therapeutics Stock Rating

Sell
36
Relay Therapeutics (RLAY) is a Sell

Is Relay Therapeutics overpriced?

  • Relay Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Relay Therapeutics Stock Price History

Is RLAY stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
relaytx.com

52-Week Data

52-Week High:
13.32
52-Week Low:
5.70

Prediction Charts

Market Cap:
881.4M
Price in USD:
6.64
Volume:
1.51M
Beta:
1.69

Technical Analysis

SMA50:
7.19
SMA100:
8.75
SMA200:
8.85
52-Wk Change:
-35.91%

Stock Predictions

  • Is Relay Therapeutics stock public?
    Yes, Relay Therapeutics is a publicly traded company.
  • What is the Relay Therapeutics stock quote today?
    The Relay Therapeutics stock price is 6.64 USD today.
  • How to buy Relay Therapeutics stock online?
    You can buy Relay Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 6.45 6.52 6.73 6.40
May-1 6.51 6.66 6.97 6.49
May-2 6.78 7.09 7.16 6.62
May-3 8.71 7.04 8.71 6.79
May-6 7.08 7.05 7.12 6.88
May-7 7.10 6.73 7.20 6.61
May-8 6.65 6.51 6.65 6.35
May-9 6.55 6.31 6.76 6.29
May-10 6.78 6.42 6.85 6.22
May-13 6.60 6.42 6.76 6.36
May-14 6.52 6.36 6.84 6.24
May-15 6.52 6.80 6.96 6.44
May-16 6.80 6.51 6.82 6.47
May-17 6.51 6.64 6.72 6.33

Relay Therapeutics Earnings

Relay Therapeutics Earnings Report: Per Share Relay Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Relay Therapeutics Forecast Revenue Growth

Relay Therapeutics Stock Analysis: Historical quarterly revenues per share for Relay Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.02 per share, an increase this year of $0.09 per share, and a decrease next year of $0.05 per share.

* Relay Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.